/clinical/,/clinical/cckm-tools/,/clinical/cckm-tools/content/,/clinical/cckm-tools/content/order-sets/,/clinical/cckm-tools/content/order-sets/inpatient/,/clinical/cckm-tools/content/order-sets/inpatient/pulmonary/,

/clinical/cckm-tools/content/order-sets/inpatient/pulmonary/name-98026-en.cckm

201712342

page

100

UWHC,UWMF,

Tools,

Clinical Hub,UW Health Clinical Tool Search,UW Health Clinical Tool Search,Order Sets,Inpatient,Pulmonary

IP - COPD Exacerbation - Adult - General Care - Supplemental [2532]

IP - COPD Exacerbation - Adult - General Care - Supplemental [2532] - Clinical Hub, UW Health Clinical Tool Search, UW Health Clinical Tool Search, Order Sets, Inpatient, Pulmonary


IP - COPD Exacerbation - Adult - General Care - Supplemental [2532]
for Adult Patients OnlyIntended
Global Initiative for Chronic Obstructive Lung
Disease Guidelines
URL: https://uconnect.wisc.edu/clinical/cckm-
tools/content/cpg/respiratory/name-97739-
en.cckm
Patient Care Orders
Respiratory [81674]
(682)If patient uses tobacco, please refer to Tobacco Abstinence Order Set Note:
Respiratory Therapy per Protocol (Includes
Inhaled Medications) [RT0035]
Routine
Protocol Type:
Oxygen Therapy [RT0032] CONTINUOUS, Starting today, Routine
FiO2 (%) Titrate to Keep Sats >/= to ___%:
Liter Flow:
Titrate oxygen to maintain O2 sat at (%): 92
O2 Delivery Device: Nasal Cannula
Attempt to Wean Off Oxygen?
Medications - General
Corticosteroids (Single Response) [81316]
prednisone (DELTASONE) tab - Total
recommended daily dose = 40 mg [41277]
20 mg, Oral, 2 X DAILY (AT MEALTIME) For 5 Days
methylprednisolone sodium succ. (SOLU-
MEDROL) intraVENOUS - NOTE: Total
recommended daily dose = 32 mg [800058]
16 mg, Intravenous, EVERY 12 HOURS For 5 Days
Beta 2 Agonists [81320]
albuterol 2.5 mg/0.5 mL neb soln [34315] 2.5 mg, Nebulization, RT 4 X DAILY
Anticholinergics [81325]
ipratropium (ATROVENT) neb soln [47883] 500 mcg, Nebulization, RT 4 X DAILY
Beta 2 Agonists - Anticholinergics [193444]
ipratropium-albuterol (DUO-NEB) 0.5-2.5 mg/3
mL neb soln [67220]
3 mL, Nebulization, RT 4 X DAILY
ipratropium-albuterol (DUO-NEB) 0.5-2.5 mg/3
mL neb soln [67220]
3 mL, Nebulization, EVERY 4 HOURS PRN, dyspnea
Anti-infectives (Single Response) [208474]
infectives: -for antiIndications
1) Sputum purulence PLUS either increased dyspnea or increased sputum volume
invasive ventilation -2) Requirement for invasive or non
Coverage of Pseudomonas aeruginosa should be considered in certain high risk patients
-(antibiotic use in the last 3 months, > 3 exacerbations in the last year, and multiple co
morbidities). If possible, sputum should be obtained for gram stain and culture.
ceftriaxone (ROCEPHIN) intraVENOUS [800027] 1 g, Intravenous, EVERY 24 HOURS
doxycycline hyclate tab [67296] 100 mg, Oral, 2 X DAILY (AT MEALTIME)
Azithromycin and Ceftriaxone [228573]
azithromycin (ZITHROMAX) intraVENOUS
[800011]
500 mg, Intravenous, EVERY 24 HOURS
ceftriaxone (ROCEPHIN) intraVENOUS [800027] 1 g, Intravenous, EVERY 24 HOURS
amoxicillin-clavulanate (AUGMENTIN) 875-125
MG per tab [70053]
1 tab, Oral, 2 X DAILY (AT MEALTIME)
ampicillin/sulbactam (UNASYN) intraVENOUS
[800010]
3 g, Intravenous, EVERY 6 HOURS
Probiotic [200227]
Page 1 of 2
Printed by BENNETT, SARA J [SJB008] at 12/8/2017 9:04:20 AM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
12/2017CCKM@uwhealth.org

-therapeutic broadconsider the use of probiotics in immunocompetent patients receiving Please
-4th generation cephalosporins, betaspectrum antibiotics, such as fluoroquinolones, 3rd and
diarrhea clindamycin to prevent antibiotic associated lactamase inhibitors, and -lactam/beta
lactobacillus rhamnosus GG (CULTURELLE) cap
[152674]
1 cap, Oral, 1 X DAILY
Laboratory
Draw Now [81677]
BLOOD GASES AND O2 SATURATION
[HCBGASOS]
NEXT DRAW, Starting today For 1 Occurrences,
STAT
Indicate FIO2:
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
CULTURE, SPUTUM WITH GRAM STAIN
[HCSPUCS]
ONCE, Starting today For 1 Occurrences, Routine,
For patients with an ET tube or tracheostomy,
quantitative mini-BAL by RT or bronchoscopic BAL are
the preferred methods of specimen collection.
If add on test, what should lab do if unable to add test
to previous specimen?
If Conditional, What Condition?
Diagnostic Tests and Imaging
General Radiography [81680]
X-RAY CHEST AP VIEW [R71010] ONCE-RAD NEXT AVAILABLE, Starting today For 1
Occurrences, Routine
Current signs and symptoms?
What specific question(s) would you like answered by
this exam?
Relevant recent/past history?
Is patient pregnant?
If being performed remotely, where? Bedside
Transport Method: Floor Determined/Entered
X-RAY CHEST PA & LAT VIEWS [R71020] ONCE-RAD NEXT AVAILABLE, Starting today For 1
Occurrences, Routine
Radiology Specialty Area: GENERAL IMAGING
Current signs and symptoms?
What specific question(s) would you like answered by
this exam?
Relevant recent/past history?
Is patient pregnant?
If being performed remotely, where?
Last patient weight? (will auto pull in value and date in
comment):
Transport Method: Floor Determined/Entered
Consults
Consults [81681]
Consult Pulmonary Medicine (Inpatient)
[CON0065]
ONCE
Intent:
Concern or Specific Question or Task to be Addressed
(Symptom, Sign, or Diagnosis): COPD exacerbation
BestPractice
No Hospital Problems have yet been identified. [107035]
Specify Hospital Problem(s) [COR0018] You will be prompted to specify a hospital problem on
signing.
Page 2 of 2
Printed by BENNETT, SARA J [SJB008] at 12/8/2017 9:04:20 AM
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
12/2017CCKM@uwhealth.org